Pharmamarketeer

FDA Needs More Safety Data on COVID-19 Vaccines, Experts Say

COVID-19 Vaccines

FRIDAY, Oct. 23, 2020 — At a meeting of the U.S. Food and Drug Administration vaccine advisory board, some experts warned that the guidelines requiring two months of safety data after a volunteer has been vaccinated were not enough, TheNew York Timesreported Thursday.

The stakes are very high, experts said. A vaccine is essential to ending the pandemic, but polls show that Americans are getting more skeptical about a vaccine and worry that the approval process is being rushed. “In this particular case, public trust equals success,” Sheldon Toubman, the consumer representative on the advisory group, told The Times. “Lack of trust means no success.”

Advertentie(s)
Geen nieuws missen?
Volg de duizenden farma professionals die Pharmamarkteer.nl via e-mail lezen

Uw inschrijving is gelukt.
Bedankt!
Naar Pharmamarkteer.nl